Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-02

Clinical Trial Update: Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous lidocaine for pain in pancreatic cancer and chronic pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Pancreatic Cancer, Chronic Pancreatitis | Phase 2 | Status: COMPLETED